|
|
|
By Erin Harris, Editor-In-Chief, Cell & Gene | Cynata Therapeutics is pioneering a scalable, iPSC-based platform to produce consistent, high-quality MSCs that are showing strong clinical promise across multiple indications, including GvHD, diabetic foot ulcers, and osteoarthritis. | |
|
|
|
| Driving Greater Efficiency Through Modular Trial Design | Article | MRN - Medical Research Network | As clinical trials grow more complex and patient-centric, traditional site-based models are proving insufficient and prompting the rise of modular, technology-enabled delivery strategies. |
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
|
|
By Diana M. Colleluori, Ph.D., MBA, and Vidhya Mathiyazhagan, MSBiologics Consulting Group Inc. | You should start with the end goal in mind, but the first draft is almost never the last. These living documents should evolve as your team gains process knowledge. | |
|
|
| Raw Material Considerations For Cell Therapies | Article | Thermo Fisher Scientific | For cell therapy developers, selecting appropriate raw materials is a significant challenge. Examine key considerations for mitigating risk and aligning with current regulatory expectations. |
|
|
| The Power Of Integrated Distribution Strategies | Webinar | Cencora | Discover the power of integrated distribution for cell and gene therapies. Learn from expert speakers how adaptable partnerships can successfully bring these innovative treatments to more patients. |
|
|
| Sustainable Freezing In Biopharma | Article | By Alexander Fuchs, Single Use Support | How does this pivot to natural gas-driven refrigeration platforms in the pharmaceutical manufacturing arena pose challenges and is sustainable cryopreservation possible? |
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|
